NHC · National Healthcare Corp
$233.55
-0.62 (-0.26%)
At close · Aug 19
Market Cap
$3.57B
Shares
15.66M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$234.17
Open$229.43
Day$227.76–234.17
52W close$107.76–234.17
Avg vol 30d112K
Short int748K · 4.8% float · 7.3d
Short vol86%
DataJan 2020–Aug 2026
Filing10-Q · Aug 6
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Low
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+38%
above
Price vs 50-day avg
+10%
above
RSI (14)
62
neutral
MACD trend
Positive
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+5%
trailing
6-month return
+46%
trailing
YTD return
+71%
this year
Relative strength
+35%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $213 › 200d $170 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +41 funds added
Insider flow
Distributing
Net -$1.3M over 90 days · 50% sells
Short interest
Rising
4.78% of float · ▲ +4.9% MoM · 7.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
250 holders — near 3-yr high, broad support
Squeeze score
66
elevated · 0–100
Fundamentals
Revenue growth
+16%
Y/Y
EPS growth
+17%
Y/Y
Free cash flow
$148.6M
Valuation
P/E 25.7
rich
Buyback
$25.0M
authorized
Balance sheet
$52.8M
net cash
Quant / Vol
risk profile
Volatility
34%
annualized · 1-yr
Max drawdown
−10%
past year
ATR
3.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+38%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
62
Neutral
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $213 › 200d $170 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +41 funds added
Insider flow
Distributing
Net -$1.3M over 90 days · 50% sells
Short interest
Rising
4.78% of float · ▲ +4.9% MoM · 7.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
250 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $108
Now $234 · 100%
Range high $234
vs 200-day avg +38%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| assisted living communities | 26 | As of August 1, 2026 | — |
| assisted living units | 1,413 | As of August 1, 2026 | — |
| Average Skilled Nursing Per Diem | $366.88 | Three Months Ended June 30, 2026 | — |
| homecare agencies | 34 | As of August 1, 2026 | — |
| hospice agencies | 33 | As of August 1, 2026 | — |
| independent living units | 775 | As of August 1, 2026 | — |
| Non-GAAP diluted earnings per share non-GAAP | $1.74 | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP diluted earnings per share $2.54
-$0.06 Unrealized gains on marketable equity securities
+$0.13 Stock-based compensation expense
-$1.15 National management fee revenue from prior periods
+$0 Gain on sale of property and equipment
+$0.28 Income tax provision on non-GAAP adjustments
= Non-GAAP diluted earnings per share $1.74
|
|||
| Non-GAAP Net income non-GAAP | $27.55M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income attributable to National Healthcare Corporation 40.32M
-915K Unrealized gains on marketable equity securities
+1.99M Stock-based compensation expense
-18.33M National management fee revenue from prior periods
+0K Gain on sale of property and equipment
+4.49M Income tax provision on non-GAAP adjustments
= Non-GAAP Net income 27.55M
|
|||
| skilled nursing beds | 10,323 | As of August 1, 2026 | — |
| skilled nursing facilities | 80 | As of August 1, 2026 | — |
| Total Skilled Nursing Patient Days | 749,723 | Three Months Ended June 30, 2026 | — |
| Adjusted diluted earnings per share non-GAAP | $6.65 | year ended December 31, 2025 | — |
| Same-facility net operating revenues | 8.4% | year ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHC
this stock
National Healthcare Corp
|
$3.57B | +70.8% | +16.1% | 25.7 | 4.8% |
|
HCA
HCA Healthcare, Inc.
|
$90.30B | -11.8% | +7.1% | 14.0 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.84B | -4.5% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.76B | +36.0% | +0.9% | 10.4 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.69B | -1.1% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHC | +8.1% | +5.1% | +46.1% | +3.6% | +70.8% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +8.5% | +2.5% | +35.3% | +0.9% | +58.3% |
Capital returns
Latest dividend
$0.67
/ share · ex Jun 30, 2026
Declared · upcoming
$0.67
/ share · ex Sep 30, 2026
Paid (TTM)
$2.59
/ share · 4 payouts
Dividend yield (TTM, derived)
1.11%
Buyback program
· as of Aug 31, 2019
Authorized
$25.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.